RB1 and cancer: The retinoblastoma protein (pRb)–E2F pathway is a central player in the control of cell cycle progression in diverse cell types and its deregulation of primary importance in proliferative disease such as cancer, where aberrant pRb activity occurs through a variety of oncogenic mechanisms (1).